Viruses and idiopathic pulmonary fibrosis

Monaldi Archives for Chest Disease

Volumn 55, Issue 2, 2000, Pages 146-150

  Lok, S S ^a   Egan, J J ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Aetiology; Idiopathic pulmonary fibrosis; Viruses

Indexed keywords

CLINICAL TRIAL; DISEASE COURSE; EPSTEIN BARR VIRUS; FIBROSING ALVEOLITIS; HEPATITIS C VIRUS; HUMAN; HUMAN ADENOVIRUS; HUMAN CYTOMEGALOVIRUS; REVIEW; VIRUS INFECTION;

EID: 0034119696     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. - Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 3471: 284-289.
2. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. - Idiopathic pulmonary fibrosis: epidemiological approaches to occupational exposure. Am J Respir Crit Care Med 1994; 150: 670-675.
3. Musk AW, Kilko PJ, Manners P, Kay PH, Kamboh MI. - Genetic studies in familial fibrosing alveolitis. Chest 1986; 89: 206-210.
4. Evans C. - HLA antigens in diffuse fibrosing alveolitis. Thorax 1976; 31: 483.
5. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. - Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976; 85: 769-788.
6. Fulmer JD, Sposovska MS, von Gal ER, Crystal RG, Mittal KK. - Distribution of HLA antigens in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1978; 118: 141-147.
7. 1-Antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977; i: 1049-1051.
8. Ueda T, Ohta K, Suzuki N, et al. - Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146: 266-268.
9. Matsuse T, Hayashi S, Kuwano K, Wilke TA, Hogg JC. - Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146: 177-184.
10. Yonemaru M, Kasuga I, Kusumoto H, et al. - Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J 1997; 10: 2040-2045
11. Egan JJ, Stewart JP, Hasleton PS, Arrand JP, Carroll KB, Woodcock AA. - Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50: 1234-1239.
12. Irving WL, Day S, Johnston IDA. - Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993; 148: 1683-1684.
13. Meliconi R, Andreone P, Fasano L, et al. - Incidence of hepatitis C virus in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996; 51: 315-317.
14. Kiyosawa K, Tanka E, Sodeyama T, et al. - Transmission of hepatitis C in an isolated area in Japan: community acquired infection. Gastroenterotogy 1994; 106: 1596-1602.
15. Hogg JC, Hegele RG. - Adenovirus and Epstein-Barr virus in lung disease. Semin Respir Infect 1995; 10: 224-253.
16. Kuwano K, Nomoto Y, Kunitake R, et al. - Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J 1997; 10: 1445-1449.
17. Kline JN, Swiderski R, Businga T, Floerchinger C, Hunninghake GW. - Induction of pulmonary fibrosis in Balb/c mice by bleomycin following infection with cytomegalovirus. Am J Respir Crit Care Med 1997; 155: A316.
18. Vergnon JM, Vincent M, De The G, Mornex JF, Weynets P, Brune J. - Cryptogenic fibrosing alveolitis and Epstein Barr virus: an association. Lancet 1984; ii: 768-770.
19. Tsukamoto K, Hayakawa H, Sato A, Suda T, Chida K, Nakamura H. - Epstein-Barr virus latent membrane protein-1 is involved in disease progression in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: A495.
20. Niedobitek G, Young LS, Lau R, et al. - Epstein-Barr infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol 1991; 72: 3035-3046.
21. Parkonen P, Hyoty H, Ilonen J, Reijoen H, Yla-Herttuala S, Leinikki P. - Antibody reactivity to an Epstein-Barr virus BERF4 encoded epitope occurring also in Asp-57 region of HLA DQ8 B chain. Clin Exp Imnumol 1994; 95: 287-293.
22. Wangoo A, Shaw RJ, Diss TC, Farrell PJ, du Bois RM, Nicholson AG. - Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 1997; 52: 888-891.
23. Stewart JP, Egan JJ, Ross AJ, et al. - The detection of Epstein-Barr virus DNA in lung tissue from idiopathic pulmonary fibrosis patients. Am J Respir Crit Care Med 1999, 159: 1336-1341.
24. Quddus MR, Nayer A, King TC, Jackson CL, Kuhn C. - EBV in idiopathic pulmonary fibrosis. US Can Acad Pathol 1997; 171A.
25. Nash AA, Usherwood EJ, Stewart JP. - Immunological features of murine gammaherpes virus 68. Semin Virol 1996; 7: 125-131.
26. Lok SS, Stewart JP, Hasleton PS, Egan JJ. - Murine gammaherpes virus 68: a potential co-factor for pulmonary fibrosis in a Balb/c model. Am J Respir Crit Care Med 1999; 159: A74.
27. Zhang Q, Brooks L, Busson P, et al. - Epstein-Barr virus latent membrane protein 1 increases HLA class II expression in an EBV-negative cell line. Eur J Immunol 1994; 24: 1467-1470.
28. Matsui R, Goldstern RH, Mihal K, Brody JS, Steele MP, Fine A. - Type I collagen formation in rat type II alveolar cells immortalised by viral gene products. Thorax 1994; 49: 201-206.
29. Kuwano K, Kunitake R, Kawasaki M, et al. - p21 WAF1/CIP1/Sdi11 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154: 477-483.
30. Bischolff FZ, Yim SO, Pathak S, et al. - Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortilisation. Cancer Res 1990; 50: 7979-7984.
31. Egan JJ, Hasleton PS, Quigely A, Woodcock AA. - Wild p53 protein expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: A315.
32. Klein SC, Kube D, Abts H, Diehl V, Tesch H. - Promotion of IL8, IL10, TNFα and TNFβ production by EBV infection. Leuk Res 1996, 20: 633-636.
33. Ho M. - Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant Proc 1991; 23: Suppl. 3, 104-109.